CBD oil

DRUG5 trials

Conditions

AI-related Musculoskeletal PainBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIChronic InflammationHR+ Breast CancerHealthy AdultsLoss of Appetite

Phase 1

Safety of Co-Administered CHI-554 and Alcohol

CompletedNCT05317507

Auburn UniversityHealthy Adults

Start: 2022-05-09End: 2023-03-31Updated: 2025-09-12

Phase 3

Effectiveness of Cannabinoids on Appetite in Scleroderma

CompletedNCT05416697

Khon Kaen UniversityLoss of Appetite, Malnutrition, Systemic Sclerosis

Start: 2022-11-09End: 2024-12-31Updated: 2025-02-20

Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

Not yet recruitingNCT06787118

Gustave Roussy, Cancer Campus, Grand ParisAI-related Musculoskeletal Pain, Breast Cancer Stage I, Breast Cancer Stage II +2

Start: 2025-12-31End: 2027-05-31Target: 130Updated: 2025-12-02

Phase 4

Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

CompletedNCT05209867

University of FloridaChronic Inflammation

Start: 2022-05-01End: 2022-12-12Updated: 2023-12-28

Unknown Phase

Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region

CompletedNCT04298554

Weill Medical College of Cornell UniversityMyofacial Pain, TMD, TMJ Disorder

Start: 2020-08-06End: 2022-05-29Updated: 2023-03-14

Related Papers

Safety of Co-Administered Cannabidiol (CBD) and alcohol: a Phase I study

Journal of Cannabis Research2026-06-13

Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial.

2025-10-24

Oral Cannabidiol Treatment Is Associated with an Anti-Inflammatory Gene Expression Signature in Myeloid Cells of People Living with HIV

Cannabis and Cannabinoid Research2024-01-228 citations